In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Georgetown University

http://otc.georgetown.edu

Latest From Georgetown University

Deal Watch: Fresenius Buyout Of Akorn Potentially Threatened By Data Integrity Issues

AstraZeneca takes second license of antisense candidate under 2012 pact with Ionis, this time for kidney disease. Aldeyra is working with J&J on novel immune-modulating drugs for systemic inflammatory conditions.

Deals Business Strategies

Start-Up Quarterly Statistics, Q2 2016

A review of biopharma start-up dealmaking and financing from April through June 2016, based on data from Strategic Transactions.

Financing Deals

Deals Shaping The Medical Industry, July 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2016.

BioPharmaceutical Deals

Endovascular Thrombectomy Shows No Benefit Over Standard Of Care In MR RESCUE

A National Institutes of Health-sponsored trial appears to dash hopes that CT or MR imaging can help select patients for acute stroke treatment with first-generation thrombus retrieval systems.

Medical Device
See All

Company Information

  • Industry
  • Academic and Research Institutions
UsernamePublicRestriction

Register